For research use only. Not for therapeutic Use.
Pumecitinib is a Janus kinase (JAK) inhibitor with anti-inflammatory activity[1].
| Catalog Number | I041967 |
| CAS Number | 2401057-12-1 |
| Synonyms | 2-[3-[3-amino-4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)pyrazol-1-yl]-1-propan-2-ylsulfonylazetidin-3-yl]acetonitrile |
| Molecular Formula | C17H20N8O2S |
| Purity | ≥95% |
| InChI | InChI=1S/C17H20N8O2S/c1-11(2)28(26,27)24-8-17(9-24,4-5-18)25-7-13(15(19)23-25)14-12-3-6-20-16(12)22-10-21-14/h3,6-7,10-11H,4,8-9H2,1-2H3,(H2,19,23)(H,20,21,22) |
| InChIKey | OUXYFMCMGWQWQF-UHFFFAOYSA-N |
| SMILES | CC(C)S(=O)(=O)N1CC(C1)(CC#N)N2C=C(C(=N2)N)C3=C4C=CNC4=NC=N3 |
| Reference | [1]. WHO Drug Information-World Health Organization (WHO). |
